查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513252

2024 年檢體有效性測試全球市場報告

Specimen Validity Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

檢體有效性測試市場規模預計在未來幾年將強勁成長。到2028年，這一數字將以9.4%的年複合成長率（CAGR）成長至52.7億美元。預測期內的成長受到多種因素的推動，包括職場藥物檢測需求的增加、口腔液檢測的採用增加、研發活動活性化、檢體有效性測試 (SVT) 的使用增加以及疼痛管理中的應用擴大。是由於以下因素造成的。預測期內的主要趨勢包括技術進步、用於結果解釋的人工智慧整合、產品創新、行業內合作夥伴關係的加強以及用於行動監測的可攜式測試設備的開發等。

藥物濫用的增加預計將在未來幾年推動檢體有效性測試 (SVT) 市場的成長。藥物濫用包括出於非醫療目的習慣性、過度或不恰當地使用合法或非法藥物，包括鴉片類藥物成癮、精神健康問題惡化、獲得治療和支持資源的機會有限以及文化因素。由於各種相互關聯的因素造成的。 SVT 方法旨在透過評估 pH、比重、肌酸酐含量和溫度等各種參數來檢測是否存在雜質和化合物。例如，健康改善和差異辦公室2023年10月公佈的資料顯示，英國成人毒品和酒精計畫的接觸次數正在增加，2021年4月至2022年3月期間接觸的總次數已從28萬次增加。上年增加29萬次。此外，根據美國疾病管制與預防中心 2022 年 5 月的數據，美國鴉片類藥物過量攝取死亡人數躍升 15%，從 2020 年的 70,029 人增加到 2021 年的80,816 人。因此，藥物濫用發生率的增加預計將推動檢體有效性測試市場的成長。

檢體有效性測試市場的主要企業正在專注於開發高解析度尿液藥物測試圖譜等創新產品，以維持其在市場中的地位。高解析度尿液藥物測試配置檔案採用先進的分析技術進行進階測試。例如，2022 年 7 月，梅奧診所實驗室發布了資料，旨在為醫生提供全面的資訊，以管理對處方鴉片類藥物、酒精、大麻和尼古丁等常見物質成癮的患者，介紹驅動尿液藥物測試(UDT) 概況。此成癮醫學監測概況 (Mayo ID ADMPU) 遵循美國成癮醫學協會指南，可檢測各種藥物類別的母體藥物和代謝物，包括鴉片類藥物、苯二氮平類藥物、興奮劑和 PCP。此概況利用高解析度、高精度質譜和標靶免疫檢測，為醫療保健提供者提供臨床相關資訊。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球檢體有效性測試市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球檢體有效性測試市場表現：規模與成長，2018-2023
  • 全球檢體有效性測試市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球檢體有效性測試市場，按產品和服務、性能和預測，2018-2023、2023-2028、2033
  • 產品
  • 服務
  • 全球檢體物有效性測試市場，依測試類型、實際和預測，2018-2023、2023-2028、2033
  • 臨床檢查
  • 快速或就地檢驗
  • 全球檢體物有效性測試市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 戒毒康復中心
  • 藥物篩檢實驗室
  • 疼痛管理中心
  • 刑事司法和執法
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球檢體有效性測試市場：按地區、表現和預測，2018-2023、2023-2028、2033
  • 全球檢體有效性測試市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 檢體有效性測試市場：競爭格局
  • 有效性測試市場檢體：公司簡介
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers
    • Medline Industries Inc.

第31章 其他重大及創新企業

  • Becton, Dickinson and Company
  • Laboratory Corporation
  • Quest Diagnostics Incorporated
  • Alere Inc.
  • Clinical Reference Laboratory Inc.
  • Precision Diagnostics
  • ACM Global Laboratories
  • Millennium Health
  • Omega Laboratories Inc.
  • Dominion Diagnostics
  • CannAmm
  • Sciteck Inc.
  • Starplex Scientific Inc.
  • Vision Diagnostics Inc.
  • Premier Biotech Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18239

Specimen Validity Testing (SVT) is a crucial process utilized to evaluate the integrity and authenticity of biological specimens, including urine, blood, saliva, or hair samples, collected for drug testing or clinical analysis. SVT scrutinizes diverse parameters such as pH, creatinine levels, specific gravity, and the presence of common masking agents such as oxidizing adulterants, nitrites, glutaraldehyde, and pyridinium chlorochromate.

Within the specimen validity testing market, products and services are the main offerings. Products encompass assay kits, reagents, calibrators, and disposables employed in the testing procedure to identify any adulteration, dilution, or substitution in urine samples. Various testing types include laboratory testing and rapid or point-of-care testing, catering to a range of end-users such as drug rehabilitation centers, drug screening laboratories, pain management centers, criminal justice and law enforcement agencies, among others.

The specimen validity testing market research report is one of a series of new reports from The Business Research Company that provides specimen validity testing market statistics, including the specimen validity testing industry global market size, regional shares, competitors with a specimen validity testing market share, detailed specimen validity testing market segments, market trends, and opportunities, and any further data you may need to thrive in the specimen validity testing industry. This specimen validity testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The specimen validity testing market size has grown strongly in recent years. It will grow from $3.37 billion in 2023 to $3.68 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.

The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.27 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The projected growth in the forecast period can be attributed to several factors, including the increasing demand for workplace drug testing, the growing adoption of oral fluid testing methods, a rise in research and development activities, the expanding utilization of Specimen Validity Testing (SVT), and the broadening applications in pain management. Key trends expected in the forecast period encompass technological advancements, the integration of artificial intelligence for result interpretation, product innovations, increasing partnerships within the industry, and the development of portable testing devices for on-the-go monitoring.

The increasing prevalence of drug abuse is anticipated to drive the growth of the specimen validity testing (SVT) market in the future. Drug abuse involves the habitual, excessive, or inappropriate use of legal or illegal substances for non-medical purposes and is on the rise due to various interconnected factors, including opioid addiction, escalating mental health issues, limited access to treatment and support resources, and cultural influences. SVT methods are designed to detect the presence of impurities and compounds by assessing various parameters such as pH, specific gravity, creatinine content, and temperature. For example, data from the Office for Health Improvement and Disparities in October 2023 revealed an increase in adult contacts with drug and alcohol programs in the UK, totaling 0.29 million interactions from April 2021 to March 2022, up from 0.28 million the previous year. Additionally, according to the Centers for Disease Control and Prevention in May 2022, opioid overdose deaths in the USA surged by 15%, reaching 80,816 in 2021 from 70,029 in 2020. Hence, the growing incidence of drug abuse is expected to propel the growth of the specimen validity testing market.

Key players in the specimen validity testing market are focused on developing innovative products such as high-resolution urine drug testing profiles to maintain their market position. A high-resolution urine drug testing profile employs advanced analytical techniques for sophisticated testing. For instance, in July 2022, Mayo Clinic Laboratories introduced a data-driven urine drug testing (UDT) profile aimed at providing physicians with comprehensive information to manage patients addicted to common substances such as prescription opioids, alcohol, marijuana, and nicotine. This addiction medicine monitoring profile (Mayo ID ADMPU) complies with the American Society of Addiction Medicine's guidelines and offers enhanced sensitivity and specificity to detect parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. Utilizing high-resolution, accurate mass spectrometry and targeted immunoassay testing, the profile delivers clinically relevant information for healthcare providers.

In October 2021, Mesa Laboratories Inc. acquired Agena Bioscience for $300 million, aiming to expand its presence in the clinical genomics sector by integrating Agena Bioscience's innovative molecular diagnostics tools and genetic analysis solutions into its portfolio. This strategic move enhances Mesa's capabilities in providing critical quality control solutions for the pharmaceutical, healthcare, and medical device industries. Agena Bioscience, known for its cutting-edge technologies and groundbreaking molecular genomics research, including sample validity testing, aligns well with Mesa Laboratories' objectives in advancing diagnostic solutions.

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd.

North America was the largest region in the specimen validity testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the specimen validity testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specimen validity testing market includes revenues earned by entities by creatinine testing, pH testing, adulterant testing, and specific gravity measurement and related specimen collection containers, urine test strips, adulterant detection kits, and temperature strips. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specimen Validity Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specimen validity testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for specimen validity testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The specimen validity testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Products; Service
  • 2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing
  • 3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers ; Medline Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Specimen Validity Testing Market Characteristics

3. Specimen Validity Testing Market Trends And Strategies

4. Specimen Validity Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Specimen Validity Testing Market Size and Growth

  • 5.1. Global Specimen Validity Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Specimen Validity Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Specimen Validity Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Specimen Validity Testing Market Segmentation

  • 6.1. Global Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Products
  • Service
  • 6.2. Global Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Testing
  • Rapid Or Point-Of-Care Testing
  • 6.3. Global Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Rehabilitation Centers
  • Drug Screening Laboratories
  • Pain Management Centers
  • Criminal Justice And Law Enforcement Agencies
  • Other End-Users

7. Specimen Validity Testing Market Regional And Country Analysis

  • 7.1. Global Specimen Validity Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Specimen Validity Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Specimen Validity Testing Market

  • 8.1. Asia-Pacific Specimen Validity Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Specimen Validity Testing Market

  • 9.1. China Specimen Validity Testing Market Overview
  • 9.2. China Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Specimen Validity Testing Market

  • 10.1. India Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Specimen Validity Testing Market

  • 11.1. Japan Specimen Validity Testing Market Overview
  • 11.2. Japan Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Specimen Validity Testing Market

  • 12.1. Australia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Specimen Validity Testing Market

  • 13.1. Indonesia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Specimen Validity Testing Market

  • 14.1. South Korea Specimen Validity Testing Market Overview
  • 14.2. South Korea Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Specimen Validity Testing Market

  • 15.1. Western Europe Specimen Validity Testing Market Overview
  • 15.2. Western Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Specimen Validity Testing Market

  • 16.1. UK Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Specimen Validity Testing Market

  • 17.1. Germany Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Specimen Validity Testing Market

  • 18.1. France Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Specimen Validity Testing Market

  • 19.1. Italy Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Specimen Validity Testing Market

  • 20.1. Spain Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Specimen Validity Testing Market

  • 21.1. Eastern Europe Specimen Validity Testing Market Overview
  • 21.2. Eastern Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Specimen Validity Testing Market

  • 22.1. Russia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Specimen Validity Testing Market

  • 23.1. North America Specimen Validity Testing Market Overview
  • 23.2. North America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Specimen Validity Testing Market

  • 24.1. USA Specimen Validity Testing Market Overview
  • 24.2. USA Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Specimen Validity Testing Market

  • 25.1. Canada Specimen Validity Testing Market Overview
  • 25.2. Canada Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Specimen Validity Testing Market

  • 26.1. South America Specimen Validity Testing Market Overview
  • 26.2. South America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Specimen Validity Testing Market

  • 27.1. Brazil Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Specimen Validity Testing Market

  • 28.1. Middle East Specimen Validity Testing Market Overview
  • 28.2. Middle East Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Specimen Validity Testing Market

  • 29.1. Africa Specimen Validity Testing Market Overview
  • 29.2. Africa Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Specimen Validity Testing Market Competitive Landscape And Company Profiles

  • 30.1. Specimen Validity Testing Market Competitive Landscape
  • 30.2. Specimen Validity Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Medline Industries Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Specimen Validity Testing Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Laboratory Corporation
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Alere Inc.
  • 31.5. Clinical Reference Laboratory Inc.
  • 31.6. Precision Diagnostics
  • 31.7. ACM Global Laboratories
  • 31.8. Millennium Health
  • 31.9. Omega Laboratories Inc.
  • 31.10. Dominion Diagnostics
  • 31.11. CannAmm
  • 31.12. Sciteck Inc.
  • 31.13. Starplex Scientific Inc.
  • 31.14. Vision Diagnostics Inc.
  • 31.15. Premier Biotech Inc.

32. Global Specimen Validity Testing Market Competitive Benchmarking

33. Global Specimen Validity Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Specimen Validity Testing Market

35. Specimen Validity Testing Market Future Outlook and Potential Analysis

  • 35.1 Specimen Validity Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Specimen Validity Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Specimen Validity Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer